Engineers Gate Manager’s AMAG Pharmaceuticals AMAG Stock Holding History

Engineers Gate Manager’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,002	Closed	-$134K	–	2092
2019 Q4	$134K	Sell	11,002 -15,136	-58%	-$165K	0.01%	1521
2019 Q3	$302K	Buy	26,138 +6,260	+31%	+$65.9K	0.02%	1001
2019 Q2	$199K	Buy	+19,878	New	+$214K	0.01%	993
2017 Q1	–	Sell	-31,245	Closed	-$1.09M	–	814
2016 Q4	$1.09M	Buy	+31,245	New	+$933K	0.12%	304
2015 Q4	–	Sell	-79,463	Closed	-$3.16M	–	848
2015 Q3	$3.16M	Buy	+79,463	New	+$4.93M	0.27%	141

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Engineers Gate Manager's AMAG Position: Q1 2020 in Review

Engineers Gate Manager sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 11,002 shares — an estimated $134K sold.

Engineers Gate Manager first reported a position in AMAG in Q3 2015 and held it in 5 quarters. The position peaked at $3.16M in Q3 2015. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

Engineers Gate Manager reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Engineers Gate Manager sold 11,002 AMAG Pharmaceuticals shares in Q1 2020, an estimated $134K.
Engineers Gate Manager first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Engineers Gate Manager's AMAG Pharmaceuticals position peaked at $3.16M in Q3 2015.
119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on Engineers Gate Manager's 13F filing for Q1 2020, filed 15 May 2020.